EPElias Peloewetse

Elias Peloewetse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elias Peloewetse has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Beatrice Greco

    Pan African Vivax and Ovale Network, Faculty of Computer and Allied Health Sciences, Regent University College of Science and Technology, McCarthy Hill, Accra P.O. Box DS1636, Ghana

    2 shared publications
  • Claude Oeuvray

    Pan African Vivax and Ovale Network, Faculty of Computer and Allied Health Sciences, Regent University College of Science and Technology, McCarthy Hill, Accra P.O. Box DS1636, Ghana

    2 shared publications
  • Daniel H. Haiyambo

    Department of Human, Biological and Translational Medical Sciences, Faculty of Health Sciences and Veterinary Medicine, University of Namibia School of Medicine, Hage Geingob Campus, Windhoek Private Bag 13301, Namibia

    2 shared publications
  • Davies Ntebela

    National Malaria Program, Ministry of Health, Gaborone Private Bag 0038, Botswana

    2 shared publications
  • Giacomo Maria Paganotti

    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania

    2 shared publications
  • Isaac Kweku Quaye

    Pan African Vivax and Ovale Network, Faculty of Computer and Allied Health Sciences, Regent University College of Science and Technology, McCarthy Hill, Accra P.O. Box DS1636, Ghana

    2 shared publications

Latest Publications

  • Open Access

    Malaria Elimination in Africa: Rethinking Strategies for Plasmodium vivax and Lessons from Botswana

    by Isaac K. Quaye, Larysa Aleksenko, Giacomo M. Paganotti, Elias Peloewetse, Daniel H. Haiyambo, Davies Ntebela, Claude Oeuvray, Beatrice Greco, the PAVON Consortium

    The global malaria community has picked up the theme of malaria elimination in more than 90% of the world’s population in the next decade. Recent reports of Plasmodium vivax (P. vivax) in sub-Saharan Africa, including in Duffy-negative individuals, threaten the efforts aimed at achieving elimination. This is not only in view of strategies that are tailored only to P. falciparum elimination but also due to currently revealed biological characteristics of P. vivax concerning the relapse patterns of hypnozoites and conservation of large biomasses in cryptic sites in the bone marrow and spleen. A typical scenario was observed in Botswana between 2008 and 2018, which palpably projects how P. vivax could endanger malaria elimination efforts where the two parasites co-exist. The need for the global malaria community, national malaria programs (NMPs), funding agencies and relevant stakeholders to engage in a forum to discuss and recommend clear pathways for elimination of malaria, including P. vivax, in sub-Saharan Africa is warranted.


  • Open Access

    Malaria Elimination in Africa: Rethinking Strategies for P. vivax and Lessons From Botswana

    by Isaac K. Quaye, Larysa Aleksenko, Giacomo M. Paganotti, Elias Peloewetse, Daniel H. Haiyambo, Davies Ntebela, Claude Oeuvray, Beatrice Greco

    The global malaria community has picked up the theme of malaria elimination in greater than 90 % of the world’s population in the next decade. The recent reports of P. vivax in all sub-Saharan Africa, including Duffy negative individuals, threaten the efforts to achieve elimination. This is not only in view of strategies that are tailored only to P. falciparum elimination, but also due to currently revealed biological characteristics of P. vivax concerning the relapse patterns of hypnozoites and conservation of a large biomass at cryptic sites in the bone marrow and spleen. A typical scenario has been observed in Botswana from the period between 2008 to 2018, which palpably projects how P. vivax could endanger efforts at malaria elimination where the two parasites co-exist. The need for the global malaria community, NMPs, funding agencies and relevant stakeholders to engage in a forum to discuss and recommend clear pathways for sub-Saharan Africa regarding malaria elimination including P. vivax, is warranted.